DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 125 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,375,506 | -14.1% | 244,957 | +3.0% | 0.02% | -15.4% |
| Q1 2024 | $3,927,596 | +50.3% | 237,748 | +32.9% | 0.03% | +52.9% |
| Q4 2023 | $2,612,436 | +55.8% | 178,934 | +30.9% | 0.02% | +30.8% |
| Q3 2023 | $1,677,309 | +21.6% | 136,700 | +18.3% | 0.01% | +8.3% |
| Q2 2023 | $1,379,284 | -1.7% | 115,518 | +10.1% | 0.01% | -7.7% |
| Q1 2023 | $1,403,047 | -43.6% | 104,940 | -9.1% | 0.01% | -38.1% |
| Q4 2022 | $2,485,560 | +431.1% | 115,500 | +393.9% | 0.02% | +425.0% |
| Q3 2022 | $468,000 | -35.2% | 23,387 | -42.0% | 0.00% | -42.9% |
| Q2 2022 | $722,000 | – | 40,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |